Recruiting
Phase 1
Phase 2

STM-416

Sponsor:

SURGE Therapeutics

Code:

NCT05710848

Conditions

Non-muscle-invasive Bladder Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

STM-416

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by SURGE Therapeutics on 2024-12-06.